IP Library Assignment 047658/0862
Patent Assignment
Reel/Frame 047658/0862

Change of Name

Recorded: 2018-05-17 Pages: 40
Assignor
NABRIVA THERAPEUTICS AG
Executed: 2017-10-19
Assignee
NABRIVA THERAPEUTICS GMBH
LEBERSTRASSE 20, VIENNA, 1110, AUSTRIA
Covered Properties (2)
Enantiomerically Pure Amines
Patent: 8,987,498 →
Application: 13/699,585 →
Publication: US 2013/0072711
Process for the Preparation of Pleuromutilins
Patent: 9,120,727 →
Application: 13/699,589 →
Publication: US 2013/0079400
Related Assignments (11)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 27, 2012
From: RIEDL, ROSEMARIE; HEILMAYER, WERNER; SPENCE, LEE; BULUSU, ATCHYUTA RAMA CHANDRA MURTY
To: NABRIVA THERAPEUTICS AG
Reel/Frame 029355/0554 →
Assignment of Assignor's Interest Dec 10, 2012
From: RIEDL, ROSEMARIE; HEILMAYER, WERNER; SPENCE, LEE
To: NABRIVA THERAPEUTICS AG
Reel/Frame 029439/0875 →
Lien Sep 3, 2014
From: NABRIVA THERAPEUTICS AG
To: KREOS CAPITAL IV (UK) LIMITED
Reel/Frame 033659/0216 →
Release of Security Interest Nov 19, 2015
From: KREOS CAPITAL IV (UK) LIMITED
To: NABRIVA THERAPEUTICS AG
Reel/Frame 037093/0308 →
Corrective Assignment to Correct the Application No. in the Release by Secured Party from 12/699585 to 13/699585 Previously Recorded on Reel 037093 Frame 0308. Assignor(S) Hereby Confirms the Release Agreement. Dec 2, 2015
From: KREOS CAPITAL IV (UK) LIMITED
To: NABRIVA THERAPEUTICS AG
Reel/Frame 037190/0424 →
Intellectual Property Security Agreement Dec 20, 2018
From: NABRIVA THERAPEUTICS GMBH
To: HERCULES CAPITAL, INC.
Reel/Frame 047973/0110 →
Security Interest Jan 18, 2019
From: NABRIVA THERAPEUTICS GMBH
To: HERCULES CAPITAL, INC.
Reel/Frame 048062/0807 →
Release of Security Interest Mar 3, 2023
From: HERCULES CAPITAL, INC.
To: NABRIVA THERAPEUTICS GMBH; ZAVANTE THERAPEUTICS, INC.
Reel/Frame 062881/0090 →
Corrective Assignment to Correct the Receiving Party Data and the Assignment Document Previously Recorded at Reel: 062881 Frame: 0090. Assignor(S) Hereby Confirms the Release of Security Interest. Jun 20, 2023
From: HERCULES CAPITAL, INC.
To: NABRIVA THERAPEUTICS GMBH
Reel/Frame 064312/0350 →
Assignment of Assignor's Interest Jan 9, 2025
From: NABRIVA THERAPEUTICS GMBH
To: HONG KONG KING-FRIEND INDUSTRIAL COMPANY LTD.
Reel/Frame 069806/0458 →
Nunc Pro Tunc Assignment Apr 3, 2025
From: NABRIVA THERAPEUTICS GMBH
To: HONG KONG KING-FRIEND INDUSTRIAL COMPANY LTD.
Reel/Frame 070725/0291 →